CLOV Biopharma

CLOV Biopharma Corp. is focused on conducting further research and development of cedar leaf oil vapor (“CLOV”) for the purposes of preventing the spread of Coronavirus and other similar potentially pathogenic respiratory viruses, for example, influenza and para-influenza viruses, and respiratory syncytial viruses. On February 14th, 2020, CLOV Biopharma was acquired by Roadman Investments, terms of the agreement were not disclosed.

CLOV Biopharma Corp. is focused on conducting further research and development of cedar leaf oil vapor (“CLOV”) for the purposes of preventing the spread of Coronavirus and other similar potentially pathogenic respiratory viruses, for example, in...Show all

See All Exits Recent Exits

Phone:

Fax:




British Columbia, Canada

CLOV Biopharma - Investments & Acquisitions

Show Real Data CLOV Biopharma Investments
See all Recent Investments
Date Company Round Amount Co-investors
See all 0 investments